Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-402-1 | CAS number: 70210-05-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 oral acute rat > 5000 mg/Kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, test procedure in accordance with 401, meets generally accepted scientific principles, acceptable for assessment. not GLP compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- other: Tif:RAIf(SPF), F3-crosses of RII 1/Tif x RII 2/Tif
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Initial Body Weight Range: 159-193 gInitial Age: 7-8 weeksIndividual Identification: by colour code using picric acidRat food, NAFAG No. 890, NAFAG AG, Gossau, SG (Switzerland), and water were provided ad libitum.The animals were kept under conventional laboratory conditions. They were caged in groups of 5 in Macrolon cages type 3 with standardized soft wood bedding (Société Parisienne des sciures, Pantin).The animal room was air conditionned: temperature 22±3° C, relative humidity 55+15%, 12 hours light/day, approximately 15 air changes/h.
- Route of administration:
- oral: gavage
- Vehicle:
- other: distilled water
- Doses:
- 2500, 5000, 7500 mg/kg
- No. of animals per sex per dose:
- 5 males and 5 females per dose
- Control animals:
- no
- Details on study design:
- Pretreatment: The animals were allocated to the different dose groups by random selection. Prior to dosing, the animals were fasted overnight.Administration: oral f by gastric intubation (gavage)Observation Period: 14 days or until all symptoms have disappeared, whichever lasts longerAdministration of the Test Article: one single dose, per osObservations and RecordsMortality: daily, a.m. and p.m. on working daysSigns and Symptoms: dailyBody weight: on days 1, 7, 14 and at deathNecropsies: Spontaneously dying animals were submitted to a gross necropsy as soon as possible; survivors at the end of the observation period.
- Statistics:
- From the body weights, the group means and their standard deviations were calculated.Where feasable, the LD50 including the 95% confidence limit were computed by the logit method (J. Berkson, J.Am. Stat. Ass. 39. 357-65, 1944)
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 1/5 female died at 5000 mg/kg dose and 3/5 females died at 7500 mg/kg dose
- Clinical signs:
- other: no specific symptoms were seen
- Gross pathology:
- No compound related gross organ changes were observed.
- Other findings:
- Spontaneously dying animals were submitted to a gross necropsy as soon as possible; survivors at the end of the observation period.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- LD50 in rats of both sexes: >5000 mg/kg bw
- Executive summary:
The aim of this study was to determine the acute oral toxicity potency of Acid violet 054 in rats, according to the OECD Guideline 401 (Acute Oral Toxicity).
The test was performed on rats (5 males and 5 females) per dose level, at three dose level: 2500, 5000 and 7500 mg/kg.
The test material was dissolved in distilled water.
The observation period was 14 days or until all symptoms have disappeared, whichever lasts longer
Prior to dosing by gastric intubation, the animals were fasted overnight. After administration, the animals were observed daily for clinical signs and mortality. Body weight was recorded immediately before administration, on day 7 and day 14.
1/5 female died at 5000 mg/kg dose and 3/5 females died at 7500 mg/kg dose. Spontaneously dying animals were submitted to a gross necropsy as soon as possible; survivors at the end of the observation period.
No specific symptoms were seen and Normal weight was gain. No compound related gross organ changes were observed.
Conclusion:following LD50 were determined
LD50 in male rats; >5000 mg/kg bw.
LD50 in female rats; > 5000 mg/kg bw.
LD50 in rats of both sexes; >5000 mg/kg bw
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
One study (Huntsman, 1982) has been chosen as key study for acute oral toxicity endpoint.
The test follows OECD 401 and it was performed on Acid violet 054.
The test was performed on rats (5 males and 5 females) per dose level, at three dose level: 2500, 5000 and 7500 mg/kg. 1/5 female died at 5000 mg/kg dose and 3/5 females died at 7500 mg/kg dose.
Spontaneously dying animals were submitted to a gross necropsy as soon as possible; survivors at the end of the observation period.
After the treatment with the tested substance, no specific symptoms were seen and normal weight was gain. No compound related gross organ changes were observed.
The LD50 in rats of both sexes is > 5000 mg/kg bw.
Another study (Huntsman, 1975) is available for Acid Violet 054 and was used as supporting.
No guideline are followed and the tested substance was administered as a single dose of 5 g/kg by gavage to rats .
After administration of the compound, the animals were observed for 14 days.
No clinical symptoms were recorded and no deaths occurred during the 14 day observation period.
At autopsy no changes in organs or tissues caused by the administration of the test compound were seen.
The acute oral median lethal dose (LD50 ) was found to be greater than 5 g/kg body weight.
A summary (Dystar, 1977) is also available for Acid Violet 054, confirming an LD50 > 5 g/kg body weight
Justification for selection of acute toxicity – oral endpoint
The study is well described and assesses the end point completely
Justification for classification or non-classification
Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1 of CLP Regulation. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). The limit value that can trigger to Classification is 2000 mg/Kg for oral and dermal exposure pattern and 5 mg/l for inhalation exposure pattern. Based on the consideration in the discussion above, no classification for acute toxicity oral is warranted under Regulation 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.